143 related articles for article (PubMed ID: 6541034)
1. On the immunopharmacology of cancer chemotherapeutics.
Spreafico F
Behring Inst Mitt; 1984 May; (74):230-8. PubMed ID: 6541034
[TBL] [Abstract][Full Text] [Related]
2. [Effect of chemotherapy on anticancer immune effector cells].
Saijo N
Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999
[TBL] [Abstract][Full Text] [Related]
3. [Biological response modifying effect of chemotherapeutic agents against cancer].
Ogura T
Gan To Kagaku Ryoho; 1984 May; 11(5):965-73. PubMed ID: 6232899
[TBL] [Abstract][Full Text] [Related]
4. [Host immunological status modification by various chemotherapeutic drugs].
Wakizaka Y; Yang ZB; Hosokawa M; Hata Y; Uchino J
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1450-2. PubMed ID: 8373203
[TBL] [Abstract][Full Text] [Related]
5. Effects of anticancer drugs on the immune system in humans.
Ehrke MJ; Mihich E; Berd D; Mastrangelo MJ
Semin Oncol; 1989 Jun; 16(3):230-53. PubMed ID: 2658084
[No Abstract] [Full Text] [Related]
6. Immunopharmacology and its toxicological problems.
Sterzl J
Arch Toxicol Suppl; 1980; 4():109-19. PubMed ID: 6159870
[TBL] [Abstract][Full Text] [Related]
7. Naturin: a potent bio-immunomodifier in experimental studies and clinical trials.
Shen RN; Lu L; Jia XQ; Wong ML; Kaiser HE
In Vivo; 1996; 10(2):201-9. PubMed ID: 8744801
[TBL] [Abstract][Full Text] [Related]
8. [Antitumor immunoadjuvant activity and the immunoregulatory mechanisms of yeasts and their components].
Marconi P; Bistoni F
Ann Ist Super Sanita; 1982; 18(3):501-8. PubMed ID: 6765083
[No Abstract] [Full Text] [Related]
9. Immunomodulation by cancer chemotherapeutic agents.
Periti P; Mini E
Chemioterapia; 1987 Dec; 6(6):399-402. PubMed ID: 3325174
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation in cancer therapeutics.
Ehrke MJ
Int Immunopharmacol; 2003 Aug; 3(8):1105-19. PubMed ID: 12860167
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Katznelson S; Wang XM; Chia D; Ozawa M; Zhong HP; Hirata M; Terasaki PI; Kobashigawa JA
J Heart Lung Transplant; 1998 Apr; 17(4):335-40. PubMed ID: 9588577
[TBL] [Abstract][Full Text] [Related]
12. Immunological aspects of cancer chemotherapy.
Zitvogel L; Apetoh L; Ghiringhelli F; Kroemer G
Nat Rev Immunol; 2008 Jan; 8(1):59-73. PubMed ID: 18097448
[TBL] [Abstract][Full Text] [Related]
13. Effect of trace element combination on the immune response of rats treated with cytostatic drug.
Elekes E; Bertók L
Acta Microbiol Immunol Hung; 1998; 45(2):221-8. PubMed ID: 9768290
[TBL] [Abstract][Full Text] [Related]
14. NK cell activity in the presence of IL-12 is a prognostic assay to neoadjuvant chemotherapy in cervical cancer.
Cosiski Marana HR; Santana da Silva J; Moreira de Andrade J
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):318-23. PubMed ID: 10985887
[TBL] [Abstract][Full Text] [Related]
15. [The effect of gentamycin on immunity in immunodeficiency and the action of immunomodulators].
Sakaeva DD; Lazareva DN
Eksp Klin Farmakol; 1998; 61(3):50-3. PubMed ID: 9690079
[TBL] [Abstract][Full Text] [Related]
16. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
17. Effect of millimeter waves on natural killer cell activation.
Makar VR; Logani MK; Bhanushali A; Kataoka M; Ziskin MC
Bioelectromagnetics; 2005 Jan; 26(1):10-9. PubMed ID: 15605409
[TBL] [Abstract][Full Text] [Related]
18. Expansion of functional NK cells in multiple tissue compartments of mice treated with Flt3-ligand: implications for anti-cancer and anti-viral therapy.
Shaw SG; Maung AA; Steptoe RJ; Thomson AW; Vujanovic NL
J Immunol; 1998 Sep; 161(6):2817-24. PubMed ID: 9743341
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by cancer chemotherapeutic agents and antineoplastic activity.
Spreafico F; Mantovani A
Pathobiol Annu; 1981; 11():177-95. PubMed ID: 6460217
[No Abstract] [Full Text] [Related]
20. [NK activities in cancer patients--their modification by an immunopotentiator].
Sasanami T; Fujishima A; Moriya Y; Imai K; Yachi A
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2186-92. PubMed ID: 7184392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
